There's never a wrong time to consider the importance of marketing to women of color, and what it takes to do it properly. Learn more about how to connect and what you need to do to get it right.
The healthcare industry is still coping with the changes the pandemic has forced upon it -- and many of these changes likely won’t be reversed. Where does pharma fit now and in 2021? Get the Intouch/DHC Group whitepaper to find out.
DTC Perspectives recently hosted a webinar – Virtual DTC National: A COVID-19 Focused Event – that addressed how the COVID-19 pandemic has so far affected patients and other pharmaceutical and healthcare stakeholders. Get key takeaways from the event and register for Intouch's new whitepaper on the aftermath of COVID-19.
Join Wendy Blackburn, Intouch Group's EVP of marketing and communications, for a FREE virtual conference hosted by DTC Perspectives on all things COVID -- May 19, 2020.
Intouch is partnering with Heart to Heart International to help stop the spread of the coronavirus through a monetary donation and more.
The COVID-19 pandemic has created new opportunities for pharmaceutical manufacturers to enhance their existing payer relationships while also delivering for HCPs and patients faced with navigating their new access and reimbursement realities.
The degree to which healthcare providers are affected by the COVID-19 pandemic depends on a number of factors. It’s important for pharma marketers to understand their mindset in these uncertain times.
New guidance from the FDA and EMA has opened the door to clinical trial protocol flexibility in order to maintain the integrity of the research currently underway. This Intouch POV looks at the challenges & opportunities for pharma marketers.
COVID-19 has upended our healthcare system and thrust pharmaceutical product patient support programs onto the front lines of treatment management. Pharmaceutical companies have the opportunity to demonstrate their commitment to patients and HCPs by ensuring that clear and relevant information is easily available.
During the coronavirus pandemic, one vitally important topic not receiving much public and media attention is how to keep the “at-risk” patient population on therapy. Intouch B2D has a plan.
